Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-012632
Filing Date
2016-04-18
Accepted
2016-04-18 17:26:16
Documents
1
Period of Report
2016-04-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4021815cicic_actinium.html 4  
1 OWNERSHIP DOCUMENT f4021815cicic_actinium.xml 4 3951
  Complete submission text file 0001213900-16-012632.txt   5535
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACTINIUM PHARMACEUTICALS, INC 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address
CICIC DRAGAN (Reporting) CIK: 0001565795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 161577523